Torrent Pharma to acquire 26% stake in Torrent Urja 27 for captive renewable power project
Ahmedabad:Torrent Pharmaceuticals Limited announced that it has entered into a Share Subscription and Shareholders' Agreement (SSSA) to acquire a 26 percent equity stake in Torrent Urja 27 Private Limited, a step-down Subsidiary of the Company’s holding Company. The Transaction is being carried out at arm’s length basis. Torrent Pharmaceuticals, headquartered in Ahmedabad, Gujarat, is a prominent Indian pharmaceutical company known for developing, manufacturing, and marketing branded and generic medications. It operates across various therapeutic areas, including cardiovascular, central nervous system, and diabetes care, with a strong presence in both regulated and emerging global markets. Read also:Torrent Pharma seeks CCI clearance to acquire majority stake in JB Pharma in Rs 19500 crore deal
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!